Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
SciLogica
AddedFeb 15, 2024
UpdatedJun 18, 2026
SciLogica

SciLogica

Pre-Seed

SciLogica develops real-time, accurate blood parameter monitoring platforms for swift medical decisions.

HQ
Denver, CO, US
Founded
2019
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize medical diagnostics, SciLogica specializes in developing real-time, accurate blood parameter monitoring platforms. Their core product, Elucido™, utilizes advanced sensor technology to continuously monitor blood gases, enabling medical teams to make swift, life-saving decisions. SciLogica aims to enhance patient outcomes and reduce hospital stays by providing highly accurate and timely blood analyte measurements.

Notable figures associated with SciLogica include leading experts in medical technology and seasoned investors committed to healthcare innovation. The company has achieved significant milestones, including successful clinical trials and partnerships with major healthcare institutions. SciLogica's impact is evident in its contribution to improved patient care and operational efficiencies in hospitals, positioning it as a key player in the medical diagnostics market.

SciLogica - Similar Companies

Sanguis logo

Sanguis

sanguiswine.com

Blood Monitoring Solutions logo

Blood Monitoring Solutions

FloBio logo

FloBio

flobiollc.com

General Fluidics logo

General Fluidics

Vena Vitals logo

Vena Vitals

venavitals.com

Scinovia logo

Scinovia

ridelogic logo

ridelogic

ridelogic.co

Alertgy logo

Alertgy

alertgy.com

VascuLogic logo

VascuLogic

Lab Me Analytics logo

Lab Me Analytics

labme.ai

Lucid Scientific logo

Lucid Scientific

lucidsci.com

Clinicai logo

Clinicai

eGlint logo

eGlint

Volumetrix logo

Volumetrix

volumetrix.com

Emerald Logic logo

Emerald Logic

SciLogica - Quick Facts

Who are SciLogica's competitors?

Companies similar to SciLogica include Sanguis, Blood Monitoring Solutions, FloBio and General Fluidics.

When was SciLogica founded?

SciLogica was founded in 2019.

Where is SciLogica's headquarters located?

SciLogica's headquarters is located in Denver, CO, US.

When was SciLogica's last funding round?

SciLogica's most recent funding round was for $1M (USD) in August 2022.

How much has SciLogica raised to-date?

As of Aug 1, 2022, SciLogica has raised a total of $2.1M (USD).

How many employees does SciLogica have?

SciLogica has 30 employees as of Feb 5, 2024.

SciLogica - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Sensors
Geographic Exposure
  • United States
Revenue
  • Software
Main Product
  • Blood Monitoring
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified